5 Rising Healthcare Stocks to Watch Now

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $0.18 in the quarter versus EPS of $-0.12 in the year-earlier quarter. Revenue Rose 213.47% to $68.9 million from the year-earlier quarter.

Arena Pharmaceuticals, Inc. reported adjusted EPS income of $0.18 per share. By that measure, the company beat the mean analyst estimate of $0.15. It beat the average revenue estimate of $57.31 million.

ARNA 20130803

Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 37.5% to $0.22 in the quarter versus EPS of $0.16 in the year-earlier quarter. Revenue Rose 28.57% to $100.5 million from the year-earlier quarter.

Auxilium Pharmaceuticals Inc. reported adjusted EPS income of $0.22 per share. By that measure, the company beat the mean analyst estimate of $-0.03. It beat the average revenue estimate of $91.43 million.

AUXL 20130803

AstraZeneca PLC (NYSE:AZN) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 21.57% to $1.2 in the quarter versus EPS of $1.53 in the year-earlier quarter. Revenue Decreased 6.43% to $6.23 billion from the year-earlier quarter.

AstraZeneca PLC reported adjusted EPS income of $1.2 per share. By that measure, the company beat the mean analyst estimate of $1.16. It missed the average revenue estimate of $6.24 billion.

AZN 20130803

Natus Medical Inc. (NASDAQ:BABY) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 75% to $0.21 in the quarter versus EPS of $0.12 in the year-earlier quarter. Revenue Rose 34.9% to $82.3 million from the year-earlier quarter.

Natus Medical Inc. reported adjusted EPS income of $0.21 per share. By that measure, the company beat the mean analyst estimate of $0.14. It missed the average revenue estimate of $83.45 million.

BABY 20130803

Becton, Dickinson and Company (NYSE:BDX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 3.95% to $1.58 in the quarter versus EPS of $1.52 in the year-earlier quarter. Revenue Rose 3.61% to $2.05 billion from the year-earlier quarter.

Becton, Dickinson and Company reported adjusted EPS income of $1.58 per share. By that measure, the company beat the mean analyst estimate of $1.48. It beat the average revenue estimate of $2.05 billion.

BDX 20130803

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.